| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 57.04▼ | 57.03▼ | 56.96▼ | 57.65▼ | 58.60▼ |
| MA10 | 57.08▼ | 56.82▲ | 56.91▲ | 58.17▼ | 57.49▼ |
| MA20 | 56.87▲ | 56.92▲ | 57.68▼ | 58.48▼ | 56.06▲ |
| MA50 | 56.85▲ | 57.78▼ | 57.93▼ | 57.50▼ | 52.73▲ |
| MA100 | 57.74▼ | 58.05▼ | 58.31▼ | 55.83▲ | 59.16▼ |
| MA200 | 57.98▼ | 58.43▼ | 57.70▼ | 51.03▲ | 60.76▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.032▲ | 0.080▲ | -0.059▼ | -0.243▼ | 0.118▲ |
| RSI | 49.938▼ | 45.762▼ | 43.280▼ | 46.575▼ | 54.013▲ |
| STOCH | 56.508 | 77.489 | 45.964 | 31.376 | 61.228 |
| WILL %R | -57.895 | -31.452 | -81.257▼ | -82.507▼ | -48.709 |
| CCI | -10.674 | 46.509 | -37.661 | -153.453▼ | 32.073 |
|
Friday, November 14, 2025 05:20 AM
Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Greetings. Welcome to the PDS Biotechnology Corporation’s Third Quarter 2025 Earnings Conference Call. At this time, all participants are ...
|
|
Thursday, November 13, 2025 07:12 AM
Get key insights from PDS Biotech’s Q3 2025 earnings call, including regulatory updates for PDS0101 in HPV16+ cancer and financial highlights.
|
|
Thursday, November 13, 2025 04:53 AM
Company Announced Completion of VERSATILE-002 Phase 2 trial of PDS0101 + Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Cancer Phase 2 Results Lead Company to Seek Expedited ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 56.67 | 57.275 | 56.10 | 57.00 | 65,799 |
| 20/11/25 | 58.59 | 60.54 | 56.53 | 56.95 | 63,450 |
| 19/11/25 | 58.11 | 58.42 | 57.09 | 58.14 | 64,831 |
| 18/11/25 | 57.54 | 58.68 | 57.39 | 58.53 | 28,780 |
| 17/11/25 | 58.60 | 59.05 | 57.57 | 57.64 | 41,998 |
| 14/11/25 | 56.55 | 58.90 | 56.34 | 58.55 | 55,800 |
| 13/11/25 | 58.60 | 59.17 | 56.43 | 56.91 | 65,800 |
| 12/11/25 | 60.72 | 61.245 | 58.63 | 58.81 | 68,167 |
| 11/11/25 | 58.90 | 60.78 | 58.47 | 60.40 | 90,900 |
| 10/11/25 | 58.49 | 59.10 | 57.8259 | 58.80 | 52,981 |
|
|
||||
|
|
||||
|
|